Riyadh - Mubasher: Nahdi Medical Company generated 1.22% lower net profits valued at SAR 654.80 million during the first nine months (9M) of 2025, compared to SAR 662.90 million in 9M-24.

Earnings per share (EPS) stood at SAR 5.04 in 9M-25, an annual decline from SAR 5.10, according to the financial results.

Meanwhile, the revenues rose by 7.63% year-on-year (YoY) to SAR 7.62 billion as of 30 September 2025 from SAR 7.08 billion. 

Financial Statements for Q3

In the third quarter (Q3) of 2025, the net profits of Nahdi Medical hit SAR 161.20 million, reflecting a 11.52% YoY jump from SAR 182.20 million. 

Revenues increased by 4.59% to SAR 2.46 billion in July-September 2025 from SAR 2.35 billion during the same period of 2024.

Quarter-on-quarter (QoQ), the Q3-25 net profits dropped by 32.38% when compared to SAR 238.40 million in Q2-25, while the revenues went down by 2.61% from SAR 2.52 billion.